Finally, baseline medical therapy differed between groups, with patients with CAD more frequently treated with antiplatelet agents, beta-blockers, calcium channel blockers, renin–angiotensin system inhibitors, nitrates, and statins (all p ≤ 0.04), reflecting both secondary prevention strategies and the higher prevalence of comorbid conditions. Here, REN is linked to coronary artery disorder.